Opinion|Videos|November 8, 2024
Personalizing Treatments and Patient Education
Key Takeaways
- Personalizing treatment regimens involves adjusting dosing schedules and administration routes to improve adherence and quality of life.
- Evaluating patient-specific factors, such as lifestyle and preferences, is crucial in developing personalized treatment plans.
Panelists discuss how treatment regimens for multiple myeloma patients can be personalized to improve adherence and quality of life by considering factors such as dosing schedules and routes of administration while emphasizing the role of pharmacists in providing resources and support to keep patients informed, engaged, and compliant with their individualized treatment plans.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can a patient's treatment regimen be personalized to improve adherence and quality of life (eg, dosing schedule, route of administration), and how are those factors weighed or evaluated when developing treatment plans?
- (Dr Adams) What resources or support can pharmacists offer to keep patients informed, engaged, and compliant with their treatment plans?
Advertisement
Related to this article
Category 1 placement for belantamab mafodotin plus bortezomib and dexamethasone puts guideline support ahead of the FDA label.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
4
The Most Accessible Healthcare Professional—But Accessible to Whom?
5